Aptitude is enabling decentralized molecular diagnostics. Our Metrix™ platform yields a result in 15-30 minutes, requires no calibration or maintenance, and has the lowest-cost instrument to enable effortless throughput scale-up without capital investment. The first test on our menu is the ONLY FDA EUA dual-sample (saliva+swab) COVID-19 test currently available in the US. We received significant funding in 2023 from BARDA, Gates Foundation, and NIH to develop a diverse test menu.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth?
YesIncluded in the Export Interest Directory?
YesBusiness Needs:
Distributor/Agent/RepresentativeCountries of Interest
Canada, United States